Skip to main content
. 2020 Jul 16;6(1):e12050. doi: 10.1002/trc2.12050

FIGURE 5.

FIGURE 5

Location of sites for Phase 2 and Phase 3 trials in the Alzheimer's disease drug development pipeline (ClinicalTrials.gov accessed February 27, 2020) (Figure by Mike de la Flor)